{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T02:18:32Z","timestamp":1773713912680,"version":"3.50.1"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,12,4]],"date-time":"2024-12-04T00:00:00Z","timestamp":1733270400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,12,4]],"date-time":"2024-12-04T00:00:00Z","timestamp":1733270400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Breast Cancer"],"published-print":{"date-parts":[[2025,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>To analyze in a prospective study the long-term safety and efficacy of 3-dimensional conformal radiotherapy (3D-CRT) to deliver accelerated partial breast irradiation (APBI) for Japanese women with early breast cancer.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Breast cancer patients with pathological tumor size\u2009\u2264\u20093\u00a0cm, age\u2009\u2265\u200920\u00a0years, lumpectomy with at least a 5\u00a0mm margin, and\u2009\u2264\u20093 positive axillary nodes were eligible. APBI was delivered by 3D-CRT at a dose of 38.5\u00a0Gy in 10 fractions over 10\u00a0days. The primary endpoints were the frequency and severity of acute and late radiation toxicities, and secondary endpoints were local control, survival, and cosmesis. The sample size was determined based on the incidence of\u2009\u2265\u2009grade 3 acute and late radiation toxicities, which required 71 enrollments.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Between 2008 and 2010, 73 patients enrolled in this trial. Twelve patients (16%) had 1\u20133 lymph node metastases. At a median follow-up of 12.6\u00a0years (range: 2.7\u201313.9\u00a0years), there were no cases of grade\u2009\u2265\u20093 acute or late toxicity. There were 4 ipsilateral breast tumor recurrence (IBTR) events: 12-year IBTR incidence was 4.4%. The difference in the incidence of IBTR between node-negative and node-positive patients was marginal (1.9% vs. 16.7%, p\u2009=\u20090.055). The majority of patients (94.4% at 2\u00a0years, 89.3% at 10\u00a0years after enrollment) had excellent\/good cosmesis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>APBI delivered with 3D-CRT is a feasible treatment option for Asian females, but it was indicated that node-positive status might increase IBTR risk.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s12282-024-01650-x","type":"journal-article","created":{"date-parts":[[2024,12,4]],"date-time":"2024-12-04T02:37:10Z","timestamp":1733279830000},"page":"197-207","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Prospective study of once-daily accelerated partial breast irradiation using 3-dimensional conformal external beam radiotherapy for Japanese women: 12-year outcomes, toxicity, and cosmesis"],"prefix":"10.1007","volume":"32","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5648-1884","authenticated-orcid":false,"given":"Kana","family":"Takahashi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshikazu","family":"Kagami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryoichi","family":"Yoshimura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Madoka","family":"Morota","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoya","family":"Murakami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoshi","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroyuki","family":"Okamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayaka","family":"Nagao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Madoka","family":"Sakuramachi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tairo","family":"Kashihara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomoya","family":"Kaneda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koji","family":"Inaba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kae","family":"Okuma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuko","family":"Nakayama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Itami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Igaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,12,4]]},"reference":[{"key":"1650_CR1","doi-asserted-by":"publisher","unstructured":"Gradishar WJ, Moran MS, Abraham J, Abramson V, Aft R, Agnese D, et al. NCCN Guidelines\u00ae Insights: Breast Cancer, Version 4.2023. J Natl Compr Canc Netw. 2023;21:594\u2013608. https:\/\/doi.org\/10.6004\/jnccn.2023.0031.","DOI":"10.6004\/jnccn.2023.0031"},{"key":"1650_CR2","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1007\/s12609-020-00384-x","volume":"12","author":"M Goldberg","year":"2020","unstructured":"Goldberg M, Whelan TJ. Accelerated partial breast irradiation (APBI): Where are we now? Curr Breast Cancer Rep. 2020;12:275\u201384. https:\/\/doi.org\/10.1007\/s12609-020-00384-x.","journal-title":"Curr Breast Cancer Rep"},{"key":"1650_CR3","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1016\/j.ijrobp.2009.02.031","volume":"74","author":"BD Smith","year":"2009","unstructured":"Smith BD, Arthur DW, Buchholz TA, Haffty BG, Hahn CA, Hardenbergh PH, et al. Accelerated partial breast irradiation consensus statement from the American society for radiation oncology (ASTRO). Int J Radiat Oncol Biol Phys. 2009;74:987\u20131001. https:\/\/doi.org\/10.1016\/j.ijrobp.2009.02.031.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1650_CR4","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.prro.2016.09.007","volume":"7","author":"C Correa","year":"2017","unstructured":"Correa C, Harris EE, Leonardi MC, Smith BD, Taghian AG, Thompson AM, et al. Accelerated partial breast irradiation: executive summary for the update of an ASTRO evidence-based consensus statement. Pract Radiat Oncol. 2017;7:73\u20139. https:\/\/doi.org\/10.1016\/j.prro.2016.09.007.","journal-title":"Pract Radiat Oncol"},{"key":"1650_CR5","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1093\/jjco\/hyab024","volume":"51","author":"M Nozaki","year":"2021","unstructured":"Nozaki M, Kagami Y, Machida R, Nakamura K, Ito Y, Nishimura Y, et al. Final analysis of a multicenter single-arm confirmatory trial of hypofractionated whole breast irradiation after breast-conserving surgery in Japan: JCOG0906. Jpn J Clin Oncol. 2021;51:865\u201372. https:\/\/doi.org\/10.1093\/jjco\/hyab024.","journal-title":"Jpn J Clin Oncol"},{"key":"1650_CR6","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1016\/S0140-6736(17)31145-5","volume":"390","author":"CE Coles","year":"2017","unstructured":"Coles CE, Griffin CL, Kirby AM, Titley J, Agrawal RK, Alhasso A, et al. Partial-breast radiotherapy after breast conservation surgery for patients with early breast cancer (UK IMPORT LOW trial): 5-year results from a multicentre, randomised, controlled, phase 3, non-inferiority trial. Lancet. 2017;390:1048\u201360. https:\/\/doi.org\/10.1016\/S0140-6736(17)31145-5.","journal-title":"Lancet"},{"key":"1650_CR7","doi-asserted-by":"publisher","first-page":"4175","DOI":"10.1200\/JCO.20.00650","volume":"38","author":"I Meattini","year":"2020","unstructured":"Meattini I, Marrazzo L, Saieva C, Desideri I, Scotti V, Simontacchi G, et al. Accelerated partial-breast irradiation compared with whole-breast irradiation for early breast cancer: long-term results of the randomized phase III APBI-IMRT-florence trial. J Clin Oncol. 2020;38:4175\u201383. https:\/\/doi.org\/10.1200\/JCO.20.00650.","journal-title":"J Clin Oncol"},{"key":"1650_CR8","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.radonc.2016.02.027","volume":"120","author":"AM Brunt","year":"2016","unstructured":"Brunt AM, Wheatley D, Yarnold J, Somaiah N, Kelly S, Harnett A, et al. Acute skin toxicity associated with a 1-week schedule of whole breast radiotherapy compared with a standard 3-week regimen delivered in the UK FAST-Forward trial. Radiother Oncol. 2016;120:114\u20138. https:\/\/doi.org\/10.1016\/j.radonc.2016.02.027.","journal-title":"Radiother Oncol"},{"key":"1650_CR9","doi-asserted-by":"publisher","first-page":"1613","DOI":"10.1016\/S0140-6736(20)30932-6","volume":"395","author":"A Murray Brunt","year":"2020","unstructured":"Murray Brunt A, Haviland JS, Wheatley DA, Sydenham MA, Alhasso A, Bloomfield DJ, et al. Hypofractionated breast radiotherapy for 1 week versus 3 weeks (FAST-Forward): 5-year efficacy and late normal tissue effects results from a multicentre, non-inferiority, randomised, phase 3 trial. Lancet. 2020;395:1613\u201326. https:\/\/doi.org\/10.1016\/S0140-6736(20)30932-6.","journal-title":"Lancet"},{"key":"1650_CR10","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1016\/j.ijrobp.2009.06.067","volume":"77","author":"F Vicini","year":"2010","unstructured":"Vicini F, Winter K, Wong J, Pass H, Rabinovitch R, Chafe S, et al. Initial efficacy results of RTOG 0319: three-dimensional conformal radiation therapy (3D-CRT) confined to the region of the lumpectomy cavity for stage I\/II breast carcinoma. Int J Radiat Oncol Biol Phys. 2010;77:1120\u20137. https:\/\/doi.org\/10.1016\/j.ijrobp.2009.06.067.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1650_CR11","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1016\/j.jaad.2012.02.010","volume":"67","author":"AP Chen","year":"2012","unstructured":"Chen AP, Setser A, Anadkat MJ, Cotliar J, Olsen EA, Garden BC, et al. Grading dermatologic adverse events of cancer treatments: the common terminology criteria for adverse events version 4.0. J Am Acad Dermatol. 2012;67:1025\u201339. https:\/\/doi.org\/10.1016\/j.jaad.2012.02.010.","journal-title":"J Am Acad Dermatol"},{"key":"1650_CR12","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1001\/archsurg.1989.01410020023002","volume":"124","author":"MA Rose","year":"1989","unstructured":"Rose MA, Olivotto I, Cady B, Koufman C, Osteen R, Silver B, et al. Conservative surgery and radiation therapy for early breast cancer. Long-term cosmetic results. Arch Surg. 1989;124:153\u20137.","journal-title":"Arch Surg"},{"key":"1650_CR13","doi-asserted-by":"publisher","first-page":"2127","DOI":"10.1007\/s12094-021-02618-5","volume":"23","author":"X Li","year":"2021","unstructured":"Li X, Sanz J, Foro P, Mart\u00ednez A, Zhao M, Reig A, et al. Long-term results of a randomized partial irradiation trial compared to whole breast irradiation in the early stage and low-risk breast cancer patients after conservative surgery. Clin Transl Oncol. 2021;23:2127\u201332. https:\/\/doi.org\/10.1007\/s12094-021-02618-5.","journal-title":"Clin Transl Oncol"},{"key":"1650_CR14","doi-asserted-by":"publisher","first-page":"2155","DOI":"10.1016\/s0140-6736(19)32514-0","volume":"394","author":"FA Vicini","year":"2019","unstructured":"Vicini FA, Cecchini RS, White JR, Arthur DW, Julian TB, Rabinovitch RA, et al. Long-term primary results of accelerated partial breast irradiation after breast-conserving surgery for early-stage breast cancer: a randomised, phase 3, equivalence trial. The Lancet. 2019;394:2155\u201364. https:\/\/doi.org\/10.1016\/s0140-6736(19)32514-0.","journal-title":"The Lancet"},{"key":"1650_CR15","doi-asserted-by":"publisher","first-page":"101324","DOI":"10.1016\/j.adro.2023.101324","volume":"9","author":"R Kumar","year":"2024","unstructured":"Kumar R, Krupa K, Yehia ZA, Kumar S, Potdevin L, Eladoumikdachi F, et al. Long-term clinical and cosmetic outcomes of once-daily accelerated partial breast irradiation in early breast cancer. Adv Radiat Oncol. 2024;9:101324. https:\/\/doi.org\/10.1016\/j.adro.2023.101324.","journal-title":"Adv Radiat Oncol"},{"key":"1650_CR16","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1016\/j.ijrobp.2009.04.070","volume":"77","author":"L Livi","year":"2010","unstructured":"Livi L, Buonamici FB, Simontacchi G, Scotti V, Fambrini M, Compagnucci A, et al. Accelerated partial breast irradiation with IMRT: new technical approach and interim analysis of acute toxicity in a phase III randomized clinical trial. Int J Radiat Oncol Biol Phys. 2010;77:509\u201315. https:\/\/doi.org\/10.1016\/j.ijrobp.2009.04.070.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1650_CR17","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1016\/j.ijrobp.2013.08.046","volume":"87","author":"N Rodriguez","year":"2013","unstructured":"Rodriguez N, Sanz X, Dengra J, Foro P, Membrive I, Reig A, et al. Five-year outcomes, cosmesis, and toxicity with 3-dimensional conformal external beam radiation therapy to deliver accelerated partial breast irradiation. Int J Radiat Oncol Biol Phys. 2013;87:1051\u20137. https:\/\/doi.org\/10.1016\/j.ijrobp.2013.08.046.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1650_CR18","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1002\/cam4.157","volume":"2","author":"S Goyal","year":"2013","unstructured":"Goyal S, Daroui P, Khan AJ, Kearney T, Kirstein L, Haffty BG. Three-year outcomes of a once daily fractionation scheme for accelerated partial breast irradiation (APBI) using 3-D conformal radiotherapy (3D-CRT). Cancer Med. 2013;2:964\u201371. https:\/\/doi.org\/10.1002\/cam4.157.","journal-title":"Cancer Med"},{"key":"1650_CR19","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.brachy.2017.09.004","volume":"17","author":"C Shah","year":"2018","unstructured":"Shah C, Vicini F, Shaitelman SF, Hepel J, Keisch M, Arthur D, et al. The American brachytherapy society consensus statement for accelerated partial-breast irradiation. Brachytherapy. 2018;17:154\u201370. https:\/\/doi.org\/10.1016\/j.brachy.2017.09.004.","journal-title":"Brachytherapy"},{"key":"1650_CR20","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/j.radonc.2010.01.014","volume":"94","author":"C Polgar","year":"2010","unstructured":"Polgar C, Van Limbergen E, Potter R, Kovacs G, Polo A, Lyczek J, et al. Patient selection for accelerated partial-breast irradiation (APBI) after breast-conserving surgery: recommendations of the Groupe Europeen de Curietherapie-European society for therapeutic radiology and oncology (GEC-ESTRO) breast cancer working group based on clinical evidence (2009). Radiother Oncol. 2010;94:264\u201373. https:\/\/doi.org\/10.1016\/j.radonc.2010.01.014.","journal-title":"Radiother Oncol"},{"key":"1650_CR21","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1016\/j.ijrobp.2016.08.042","volume":"96","author":"R Rabinovitch","year":"2016","unstructured":"Rabinovitch R, Moughan J, Vicini F, Pass H, Wong J, Chafe S, et al. Long-term update of NRG oncology RTOG 0319: a phase 1 and 2 trial to evaluate 3-dimensional conformal radiation therapy confined to the region of the lumpectomy cavity for stage I and II breast carcinoma. Int J Radiat Oncol Biol Phys. 2016;96:1054\u20139. https:\/\/doi.org\/10.1016\/j.ijrobp.2016.08.042.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1650_CR22","doi-asserted-by":"publisher","first-page":"2165","DOI":"10.1016\/s0140-6736(19)32515-2","volume":"394","author":"TJ Whelan","year":"2019","unstructured":"Whelan TJ, Julian JA, Berrang TS, Kim D-H, Germain I, Nichol AM, et al. External beam accelerated partial breast irradiation versus whole breast irradiation after breast conserving surgery in women with ductal carcinoma in situ and node-negative breast cancer (RAPID): a randomised controlled trial. The Lancet. 2019;394:2165\u201372. https:\/\/doi.org\/10.1016\/s0140-6736(19)32515-2.","journal-title":"The Lancet"},{"key":"1650_CR23","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1016\/j.ijrobp.2010.11.077","volume":"82","author":"DJ Hoopes","year":"2012","unstructured":"Hoopes DJ, Kaziska D, Chapin P, Weed D, Smith BD, Hale ER, et al. Patient preferences and physician practice patterns regarding breast radiotherapy. Int J Radiat Oncol Biol Phys. 2012;82:674\u201381. https:\/\/doi.org\/10.1016\/j.ijrobp.2010.11.077.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1650_CR24","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.prro.2023.11.001","volume":"14","author":"SF Shaitelman","year":"2024","unstructured":"Shaitelman SF, Anderson BM, Arthur DW, Bazan JG, Bellon JR, Bradfield L, et al. Partial breast irradiation for patients with early-stage invasive breast cancer or ductal carcinoma in situ: an ASTRO clinical practice guideline. Pract Radiat Oncol. 2024;14:112\u201332. https:\/\/doi.org\/10.1016\/j.prro.2023.11.001.","journal-title":"Pract Radiat Oncol"},{"key":"1650_CR25","doi-asserted-by":"publisher","first-page":"2201","DOI":"10.1200\/JCO.22.01485","volume":"41","author":"B Meduri","year":"2023","unstructured":"Meduri B, Baldissera A, Iotti C, Scheijmans L, Stam MR, Parisi S, et al. Cosmetic results and side effects of accelerated partial-breast irradiation versus whole-breast irradiation for low-risk invasive carcinoma of the breast: the randomized phase III IRMA trial. J Clin Oncol. 2023;41:2201\u201310. https:\/\/doi.org\/10.1200\/JCO.22.01485.","journal-title":"J Clin Oncol"},{"key":"1650_CR26","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1016\/j.ijrobp.2020.11.044","volume":"109","author":"RR Boutrus","year":"2021","unstructured":"Boutrus RR, El Sherif S, Abdelazim Y, Bayomy M, Gaber AS, Farahat A, et al. Once daily versus twice daily external beam accelerated partial breast irradiation: a randomized prospective study. Int J Radiat Oncol Biol Phys. 2021;109:1296\u2013300. https:\/\/doi.org\/10.1016\/j.ijrobp.2020.11.044.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1650_CR27","doi-asserted-by":"publisher","first-page":"1290","DOI":"10.1016\/j.ijrobp.2009.01.009","volume":"75","author":"JT Hepel","year":"2009","unstructured":"Hepel JT, Tokita M, MacAusland SG, Evans SB, Hiatt JR, Price LL, et al. Toxicity of three-dimensional conformal radiotherapy for accelerated partial breast irradiation. Int J Radiat Oncol Biol Phys. 2009;75:1290\u20136. https:\/\/doi.org\/10.1016\/j.ijrobp.2009.01.009.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1650_CR28","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1016\/j.ijrobp.2010.06.062","volume":"81","author":"SF Shaitelman","year":"2011","unstructured":"Shaitelman SF, Kim LH, Grills IS, Chen PY, Ye H, Kestin LL, et al. Predictors of long-term toxicity using three-dimensional conformal external beam radiotherapy to deliver accelerated partial breast irradiation. Int J Radiat Oncol Biol Phys. 2011;81:788\u201394. https:\/\/doi.org\/10.1016\/j.ijrobp.2010.06.062.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1650_CR29","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1007\/s12282-022-01339-z","volume":"29","author":"K Yoshida","year":"2022","unstructured":"Yoshida K, Nose T, Otani Y, Asahi S, Tsukiyama I, Dokiya T, et al. A Japanese prospective multi-institutional feasibility study on accelerated partial breast irradiation using multicatheter interstitial brachytherapy: clinical results with a median follow-up of 60 months. Breast Cancer. 2022;29:636\u201344. https:\/\/doi.org\/10.1007\/s12282-022-01339-z.","journal-title":"Breast Cancer"},{"key":"1650_CR30","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1007\/s12282-024-01577-3","volume":"31","author":"PJK Tokuda","year":"2024","unstructured":"Tokuda PJK, Mitsuyoshi T, Ono Y, Kishi T, Negoro Y, Okumura S, et al. Acute adverse events of ultra-hypofractionated whole-breast irradiation after breast-conserving surgery for early breast cancer in Japan: an interim analysis of the multi-institutional phase II UPBEAT study. Breast Cancer. 2024;31:643\u20138. https:\/\/doi.org\/10.1007\/s12282-024-01577-3.","journal-title":"Breast Cancer"},{"key":"1650_CR31","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.ijrobp.2021.03.052","volume":"111","author":"JM Hannoun-Levi","year":"2021","unstructured":"Hannoun-Levi JM, Montagne L, Sumodhee S, Schiappa R, Boulahssass R, Gautier M, et al. APBI versus ultra-APBI in the elderly with low-risk breast cancer: a comparative analysis of oncological outcome and late toxicity. Int J Radiat Oncol Biol Phys. 2021;111:56\u201367. https:\/\/doi.org\/10.1016\/j.ijrobp.2021.03.052.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1650_CR32","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1016\/j.ijrobp.2020.02.021","volume":"107","author":"WR Kennedy","year":"2020","unstructured":"Kennedy WR, Thomas MA, Stanley JA, Luo J, Ochoa LL, Clifton KK, et al. Single-institution phase 1\/2 prospective clinical trial of single-fraction, high-gradient adjuvant partial-breast irradiation for hormone sensitive stage 0-i breast cancer. Int J Radiat Oncol Biol Phys. 2020;107:344\u201352. https:\/\/doi.org\/10.1016\/j.ijrobp.2020.02.021.","journal-title":"Int J Radiat Oncol Biol Phys"}],"container-title":["Breast Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12282-024-01650-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12282-024-01650-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12282-024-01650-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,9]],"date-time":"2025-01-09T06:15:57Z","timestamp":1736403357000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12282-024-01650-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,4]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["1650"],"URL":"https:\/\/doi.org\/10.1007\/s12282-024-01650-x","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-4652213\/v1","asserted-by":"object"}]},"ISSN":["1340-6868","1880-4233"],"issn-type":[{"value":"1340-6868","type":"print"},{"value":"1880-4233","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,4]]},"assertion":[{"value":"28 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 November 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 December 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Informed consent was obtained from all participants included in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"All procedures performed in studies involving human participants were conducted in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Declaration of Helsinki and its later amendments or comparable ethical standards.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Research involving human participants and\/or animals"}}]}}